FORZ (Forza Innovations) ROC (Joel Greenblatt) %: 5,160.00% (As of Dec. 2023)


What is Forza Innovations ROC (Joel Greenblatt) %?

Forza Innovations FORZ -99.00% ROC (Joel Greenblatt) % is 5,160.00% as of Dec. 2023.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Forza Innovations's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5,160.00%.

The historical rank and industry rank for Forza Innovations's ROC (Joel Greenblatt) % or its related term are showing as below:

FORZ's ROC (Joel Greenblatt) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.13
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

Forza Innovations's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Forza Innovations  (OTCPK:FORZ) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Forza Innovations ROC (Joel Greenblatt) % Related Terms


Forza Innovations ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Forza Innovations's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forza Innovations ROC (Joel Greenblatt) % Chart

Forza Innovations Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 41.12 -36.82 -2,871.56 -1,640.00 -2,536.03

Forza Innovations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,192.56 -1,866.67 -2,866.19 -1,944.13 5,160.00

FORZ vs USAQ, EMED, RTSL: ROC (Joel Greenblatt) % Comparison

For the Medical Devices subindustry, Forza Innovations's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forza Innovations ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Forza Innovations's ROC (Joel Greenblatt) % falls into.



Forza Innovations ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.438 + 0 + 2.857)
=-3.295

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.488 + 0 + 1.793)
=-2.281

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Forza Innovations for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4.128/( ( (0.088 + max(-3.295, 0)) + (0.072 + max(-2.281, 0)) )/ 2 )
=4.128/( ( 0.088 + 0.072 )/ 2 )
=4.128/0.08
=5,160.00 %

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 5,160.00% mean?
Forza Innovations (FORZ) has a ROC (Joel Greenblatt) % of 5,160.00% as of Dec. 2023. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Forza Innovations and its competitors.
Is Forza Innovations' ROC (Joel Greenblatt) % too high?
Forza Innovations' current ROC (Joel Greenblatt) % is 5,160.00%. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.13. Forza Innovations' value of 5,160.00% is 124839.5% above this industry median.
How does Forza Innovations' ROC (Joel Greenblatt) % compare to USAQ and EMED?
Forza Innovations' ROC (Joel Greenblatt) % of 5,160.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROC (Joel Greenblatt) % is 4.13. Forza Innovations' value of 5,160.00% is 124839.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forza Innovations's current ROC (Joel Greenblatt) % of 5,160.00% is 124839.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Forza Innovations and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forza Innovations's current ROC (Joel Greenblatt) % is 5,160.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current ROC (Joel Greenblatt) % of 5,160.00%. The current ROC (Joel Greenblatt) % is 5,160.00% and 124839.5% above the Medical Devices & Instruments industry median of 4.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Forza Innovations (FORZ), the current ROC (Joel Greenblatt) % is 5,160.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forza Innovations Business Description

Address 406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.